13F
中

INVA INNOVIVA INC

2026Q1 · CUSIP 45781M101 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
282
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
147
Δ whales
+6
Inst. holding value
$1.7B
New positions
48
Closed positions
46
Price momentum (1Q)
-8.6%
Put / Call
0/2

Breadth history (34 quarters)

2018Q1: Δ+24 · h=222 2018Q2: Δ+1 · h=223 2018Q3: Δ-14 · h=209 2018Q4: Δ+21 · h=230 2019Q1: Δ+1 · h=231 2019Q2: Δ-20 · h=211 2019Q3: Δ-12 · h=199 2019Q4: Δ-10 · h=189 2020Q1: Δ+2 · h=191 2020Q2: Δ+9 · h=200 2020Q3: Δ+5 · h=205 2020Q4: Δ-13 · h=192 2021Q1: Δ-15 · h=177 2021Q2: Δ+6 · h=183 2021Q3: Δ+22 · h=205 2021Q4: Δ+11 · h=216 2022Q1: Δ+17 · h=233 2022Q2: Δ-17 · h=216 2022Q3: Δ-3 · h=213 2022Q4: Δ-3 · h=210 2023Q1: Δ-18 · h=192 2023Q2: Δ+7 · h=199 2023Q3: Δ-6 · h=193 2023Q4: Δ+5 · h=198 2024Q1: Δ+16 · h=214 2024Q2: Δ+1 · h=215 2024Q3: Δ+6 · h=221 2024Q4: Δ+16 · h=237 2025Q1: Δ+9 · h=246 2025Q2: Δ+19 · h=265 2025Q3: Δ-3 · h=262 2025Q4: Δ+18 · h=280 2026Q1: Δ+2 · h=282 2018Q1: holders=222 2018Q2: holders=223 2018Q3: holders=209 2018Q4: holders=230 2019Q1: holders=231 2019Q2: holders=211 2019Q3: holders=199 2019Q4: holders=189 2020Q1: holders=191 2020Q2: holders=200 2020Q3: holders=205 2020Q4: holders=192 2021Q1: holders=177 2021Q2: holders=183 2021Q3: holders=205 2021Q4: holders=216 2022Q1: holders=233 2022Q2: holders=216 2022Q3: holders=213 2022Q4: holders=210 2023Q1: holders=192 2023Q2: holders=199 2023Q3: holders=193 2023Q4: holders=198 2024Q1: holders=214 2024Q2: holders=215 2024Q3: holders=221 2024Q4: holders=237 2025Q1: holders=246 2025Q2: holders=265 2025Q3: holders=262 2025Q4: holders=280 2026Q1: holders=282 -24 -12 +0 +12 +24 159228297 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 6 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 17% +7.1% +13.9%
2024Q1 Top 19% +16.0% +18.3%
2022Q1 Top 11% -13.7% -18.0%
2021Q3 Top 7% +16.8% -8.0%
2018Q4 Top 11% -2.2% -20.3%
2018Q1 Top 7% -4.0% +10.6%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
2
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
3.5
EPS (TTM)
$6.26
EPS YoY
—
Revenue (TTM)
$0.4B
Revenue YoY
+13.8%
Quarterly Revenue & EPS (4Y)
2022-06-30: $108M 2022-09-30: $67M 2022-12-31: $66M 2023-03-31: $76M 2023-06-30: $81M 2023-09-30: $67M 2023-12-31: $86M 2024-03-31: $77M 2024-06-30: $100M 2024-09-30: $90M 2024-12-31: $92M 2025-03-31: $89M 2025-06-30: $100M 2025-09-30: $108M 2025-12-31: $115M 2026-03-31: $98M 2022-06-30: EPS 0.05 2022-09-30: EPS 2.80 2022-12-31: EPS -0.68 2023-03-31: EPS 0.42 2023-06-30: EPS 0.02 2023-09-30: EPS 0.98 2023-12-31: EPS 0.78 2024-03-31: EPS 0.46 2024-06-30: EPS -0.55 2024-09-30: EPS 0.02 2024-12-31: EPS 0.43 2025-03-31: EPS -0.74 2025-06-30: EPS 0.77 2025-09-30: EPS 1.08 2025-12-31: EPS 2.19 2026-03-31: EPS 2.22 0M 57M 115M $M -0.81 1.13 3.08 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 11 2023-03-31: PE 5.12023-06-30: PE 5.32023-09-30: PE 18.42023-12-31: PE 7.22024-03-31: PE 7.12024-06-30: PE 112024-09-30: PE 26.62024-12-31: PE 50.22025-06-30: PE 43.62025-09-30: PE 14.42025-12-31: PE 6.92026-03-31: PE 3.5 3 28 53 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)